Trading Window

Corporate Office: Plot No. 412-415, Nimai Tower, 3rd Floor, Phase-IV, Udyog Vihar, Sector-18, Gurugram -122015, Haryana (India) Ph.: +91 124 4406710; E-mail: info@jagsonpal.com; Website: www.jagsonpal.com CIN. : L74899DL1978PLC009181 September 25, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Intimation of Closure of Trading Window In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of Designated Persons, the Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited ("the Company") would remain closed for Designated Persons and their immediate relative(s) with effect from Thursday, October 01, 2026 and will open 48 (Forty Eight) hours after declaration of unaudited financial results (Standalone & Consolidated) for the quarter and six months ended on September 30, 2026. The date of Board Meeting for declaration of unaudited financial results (Standalone & Consolidated) of the Company quarter and six months ended on September 30, 2026 will be intimated in due course. We request you to take the above on record. Thanking you, Yours faithfully, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance Officer Regd. Office: Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India) Mumbai Office: 13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070